Approximately one‐half of individuals with cancer face personal economic burdens
associated with the disease and its treatment, a problem known as financial toxicity (FT). FT …

Background: With rising cancer care costs, including high-priced cancer drugs, financial
hardship is increasingly documented among cancer survivors in the United States; research …

Background: Patients with cancer experience financial toxicity from the costs of treatment, as
well as material and psychologic stress related to this burden. A synthesized understanding …

Objective To determine the extent of financial toxicity (FT) among cancer survivors, identify
the determinants and how FT is measured. Methods A systematic review was performed in …

Purpose To estimate the prevalence of financial hardship associated with cancer in the
United States and identify characteristics of cancer survivors associated with financial …

BACKGROUND Cancer‐related financial burden has been linked to cancer survivors (CS)
forgoing/delaying medical care, skipping follow‐up visits, and discontinuing medications. To …

Patients experiencing financial distress as a side-effect of cancer are not only reported in the
United States, but also in third-party payer healthcare systems in Europe. Since validated …

Background Financial toxicity has traditionally been attributed to the rising costs of cancer
care. As ability to work impacts one's financial situation, limited employment and reduced …

Background Financial toxicity is commonly reported by cancer patients, but few studies have
assessed caregiver perceptions. We aimed to validate the modified Comprehensive Score …

We commend Dr. Zafar for continuing to highlight the critical issue of financial toxicity in
cancer care and the call to action for the development of interventions to minimize the …